Homeβ€ΊStocksβ€ΊPFIZER: Pfizer Ltd

Pfizer Ltd

NSEBSEPFIZERHealthcareConcall transcript
β‚Ή3,808.20
β–² β‚Ή58.20 Β (+1.55%)
NSE Β· Last Β· 11 Oct, 06:03 pm
Price
daily

Overlay is FY EPS implied P/E (stepped), not TTM.

Quant & risk snapshot

Metrics calculated as of last available close.

1W
β€”
1M
β€”
3M
β€”
6M
β€”
1Y
β€”
P/E now
β€”
3Y CAGR
β€”
5Y CAGR
β€”
1Y vol
β€”
5Y max DD
β€”
5Y EPS CAGR
β€”
5Y rerating
β€”
64
Empire Scoreβ„’
Good Quality
5
Piotroski
5/9 F-Score
19.8%
ROE
Return on equity
27.2%
ROCE
Return on capital
GRAHAM VALUE
β‚Ή1,125.70
~238% Premium
The Numbers That Matter
End-of-day filing snapshot Β· β€” when not disclosed
β€”EV / EBITDA
Financial Health Story
Revenue
Net Profit
Data is compiled from end-of-day institutional filings for educational structural analysis. Compare with audited filings before making financial decisions. Missing bars or β€” values are normal for banks or thin coverage. Chart magnitudes are shown in β‚Ή Cr (Indian grouping).
SWOT Analysis
AI Powered

Unlock strengths, weaknesses, opportunities, and threats in clear, simple English.

Peter Lynch valuation bands

Bands from median Β±1Οƒ of FY-implied P/E over the plotted window. These are not TTM percentile bands.

Base-100 compounding

Price, revenue, and net profit rebased to 100 at the first month where all series are positive. Annual fundamentals are step-held to month-end.

Peer Comparison

Sector: HealthcareΒ· 50 sector peers

Scroll horizontally to compare all sector peers.

MetricsPFIZERYouAPOLLOHOSPApollo Hospitals Enterprise LtdCIPLACipla LtdDIVISLABDivis Laboratories LtdDRREDDYDr Reddys Laboratories LtdSUNPHARMASun Pharmaceutical Industries LtdABBOTINDIAAbbott India LtdAJANTPHARMAjanta Pharma LtdALKEMAlkem Laboratories LtdANTHEMAnthem Biosciences LtdASTERDMAster DM Quality Care LtdAUROPHARMAAurobindo Pharma LtdBIOCONBiocon LtdBLUEJETBlue Jet Healthcare LtdCAPLIPOINTCaplin Point Laboratories LtdCOHANCECohance Lifesciences LtdCONCORDBIOConcord Biotech LtdEMCUREEmcure Pharmaceuticals LtdERISERIS Lifesciences LtdFORTISFortis Healthcare LtdGLANDGland Pharma LtdGLAXOGlaxosmithkline Pharmaceuticals LtdGLENMARKGlenmark Pharmaceuticals LtdGRANULESGranules India LtdIKSInventurus Knowledge Solutions LtdINDGNIndegene LtdIPCALABIpca Laboratories LtdJBCHEPHARMJ B Chemicals & Pharmaceuticals LtdJUBLPHARMAJubilant Pharmova LtdKIMSKrishna Institute of Medical Sciences LtdLALPATHLABDr Lal Pathlabs LtdLAURUSLABSLaurus Labs LtdLENSKARTLenskart Solutions LtdLUPINLupin LtdMANKINDMankind Pharma LtdMAXHEALTHMax Healthcare Institute LtdMEDANTAGlobal Health LtdNATCOPHARMNatco Pharma LtdNEULANDLABNeuland Laboratories LtdNHNarayana Hrudayalaya LtdONESOURCEOneSource Specialty Pharma LtdPOLYMEDPoly Medicure LtdPPLPHARMAPiramal Pharma LtdRAINBOWRainbow Childrens Medicare LtdSAGILITYSagility LtdSAILIFESai Life Sciences LtdSYNGENESyngene International LtdTORNTPHARMTorrent Pharmaceuticals LtdVIJAYAVijaya Diagnostic Centre LtdWOCKPHARMAWockhardt LtdZYDUSLIFEZydus Lifesciences Ltd
Current Priceβ‚Ή3,808.2β‚Ή8,089.5β‚Ή1,379.3β‚Ή6,533β‚Ή1,274β‚Ή1,747.3β‚Ή26,295β‚Ή2,912.2β‚Ή5,239β‚Ή755.6β‚Ή726.95β‚Ή1,429.2β‚Ή416.8β‚Ή452.5β‚Ή1,988.1β‚Ή428.9β‚Ή1,166.2β‚Ή1,704.4β‚Ή1,362.1β‚Ή929.4β‚Ή2,277β‚Ή2,188.8β‚Ή2,184.6β‚Ή777.55β‚Ή1,670.2β‚Ή518.45β‚Ή1,507.7β‚Ή2,129.6β‚Ή991.75β‚Ή784.45β‚Ή1,617.2β‚Ή1,381.7β‚Ή521β‚Ή2,249.8β‚Ή2,420.4β‚Ή993.45β‚Ή1,105.55β‚Ή1,092β‚Ή14,449β‚Ή1,770.5β‚Ή1,784.8β‚Ή1,321.4β‚Ή166.29β‚Ή1,241.9β‚Ή41.74β‚Ή1,047.95β‚Ή440.25β‚Ή4,182.9β‚Ή1,513.6β‚Ή2,265.6β‚Ή1,203.9
P/E Ratio120.0Γ—59.8Γ—30.7Γ—82.9Γ—30.0Γ—35.3Γ—0.0Γ—38.8Γ—27.4Γ—87.4Γ—183.0Γ—25.4Γ—84.4Γ—77.1Γ—29.9Γ—156.0Γ—55.1Γ—34.9Γ—27.5Γ—62.8Γ—41.6Γ—45.7Γ—21.7Γ—32.7Γ—39.1Γ—33.5Γ—36.1Γ—53.8Γ—41.8Γ—155.0Γ—57.5Γ—96.3Γ—182.0Γ—16.0Γ—44.4Γ—67.2Γ—66.9Γ—12.8Γ—58.8Γ—44.5Γ—0.0Γ—54.9Γ—0.0Γ—52.6Γ—20.5Γ—89.5Γ—51.7Γ—82.2Γ—83.2Γ—92.3Γ—24.7Γ—
P/B Ratio0.0Γ—13.1Γ—3.3Γ—10.3Γ—2.6Γ—5.3Γ—0.0Γ—9.5Γ—4.6Γ—16.0Γ—14.4Γ—2.4Γ—2.0Γ—0.0Γ—5.1Γ—4.5Γ—8.0Γ—6.8Γ—4.6Γ—6.8Γ—4.4Γ—19.4Γ—5.9Γ—4.3Γ—10.6Γ—4.3Γ—5.7Γ—8.2Γ—1.9Γ—8.9Γ—12.1Γ—17.4Γ—12.2Γ—4.3Γ—5.9Γ—9.0Γ—9.4Γ—1.7Γ—14.8Γ—7.8Γ—3.0Γ—5.7Γ—3.5Γ—8.7Γ—2.0Γ—12.0Γ—3.4Γ—15.6Γ—16.3Γ—7.4Γ—4.5Γ—
ROE (%)19.8%21.2%11.6%16.5%11.2%16.0%34.7%27.1%18.9%22.3%11.3%10.1%1.4%52.1%20.9%4.9%12.5%20.1%18.7%11.2%10.7%45.6%23.6%13.8%31.4%14.4%15.7%18.9%6.5%11.3%22.3%18.3%6.3%28.7%13.1%14.7%15.2%17.1%21.2%20.5%-1.1%9.0%-3.8%15.9%10.6%15.4%7.8%27.4%18.3%6.1%21.2%
ROCE (%)27.2%17.4%15.5%22.0%13.0%20.5%46.7%34.5%21.2%30.4%11.6%12.9%3.6%57.3%24.2%5.8%17.1%24.0%14.1%13.4%15.1%61.4%39.8%15.5%31.5%18.8%17.0%25.4%9.0%9.5%28.0%17.8%8.1%29.9%13.5%14.7%17.4%17.4%26.5%15.5%57.0%12.5%2.5%17.4%13.4%19.6%10.0%15.2%20.5%7.5%21.1%
EV / EBITDAβ€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”
Dividend Yield (%)1.86%23.00%95.00%33.00%70.00%86.00%1.96%91.00%1.01%22.00%40.00%24.00%13.00%21.00%31.00%0.00%52.00%19.00%55.00%11.00%70.00%2.02%21.00%21.00%0.00%39.00%31.00%91.00%50.00%0.00%73.00%10.00%0.00%88.00%4.00%20.00%4.00%61.00%15.00%24.00%0.00%21.00%7.00%24.00%33.00%0.00%33.00%79.00%13.00%0.00%8.00%

Peer figures are drawn from the same educational filing snapshot as the main report. Missing values show β€”. EV/EBITDA and yields are often unavailable for banks. Compare filings before investing.

Corporate filings

Annual reports, investor decks, and concall links. URLs only. We do not host PDFs.

Annual reports

Newest period first.

Annual Report 2026 from bse
Annual Report 2026 from bse
Open
Financial Year 2026 from bse
Financial Year 2026 from bseLatest
Open
Annual Report 2025 from bse
Annual Report 2025 from bse
Open
Financial Year 2025 from bse
Financial Year 2025 from bse
Open
Annual Report 2024 from bse
Annual Report 2024 from bse
Open
Financial Year 2024 from bse
Financial Year 2024 from bse
Open
Annual Report 2023 from bse
Annual Report 2023 from bse
Open
Financial Year 2023 from bse
Financial Year 2023 from bse
Open
Annual Report 2022 from bse
Annual Report 2022 from bse
Open
Financial Year 2022 from bse
Financial Year 2022 from bse
Open
Annual Report 2021 from bse
Annual Report 2021 from bse
Open
Annual Report 2020 from bse
Annual Report 2020 from bse
Open
Annual Report 2019 from bse
Annual Report 2019 from bse
Open
Annual Report 2018 from bse
Annual Report 2018 from bse
Open
Annual Report 2017 from bse
Annual Report 2017 from bse
Open
Annual Report 2016 from bse
Annual Report 2016 from bse
Open
Annual Report 2015 from bse
Annual Report 2015 from bse
Open

Investor presentations

Newest period first.

None indexed yet.

Concall transcripts

Newest period first.

Concall transcript β€” Aug 2020
Aug 2020Latest
Open
Concall transcript β€” May 2017
May 2017
Open
Concall transcript β€” Feb 2017
Feb 2017
Open
Concall transcript β€” Nov 2016
Nov 2016
Open
Concall transcript β€” Aug 2016
Aug 2016
Open
Concall transcript β€” May 2016
May 2016
Open
Concall transcript β€” Feb 2016
Feb 2016
Open
Technical Snapshot
Educational only
Technical data shown for educational purposes. Not investment advice.
Financial Health Checklist
5/9 passΒ· 3 data N/A
N/A
Quarterly revenue growthData unavailable for this sector.
N/A
Net profit trendData unavailable for this sector.
PASS
ROEROE 19.8% (β‰₯15%).
PASS
ROCEROCE 27.2% (β‰₯12%).
PASS
Debt / EquityD/E 0.00 (<1.0).
PASS
Net marginNet margin 34.4% (β‰₯10%).
FAIL
P/E ratioP/E 120.0Γ— (β‰₯60).
N/A
EV / EBITDAData unavailable for this sector.
PASS
Dividend yieldYield 1.86% (β‰₯1.5%).

N/A means the metric is not available in the educational dataset (common for banks or thin coverage). Those rows are not scored as fail.

Institutional ratios

Piotroski F-Score, Altman Z, cash conversion cycle, and PEG. Derived from the same filing-based fundamentals as the rest of the report (indicative only, not investment advice).

Piotroski F-Score
5/9
Altman Z-Score
22.72Safe
Cash conversion cycle
β€”
PEG ratio
2.28
Latest News
Tap a headline Β· Quick read
Loading headlines…